Literature DB >> 5789813

Liberation of a bradykinin-like substance in the circulating blood of dogs by trypsin, chymotrypsin and nagarse.

S H Ferreira, M Rocha E Silva.   

Abstract

1. Using the blood-bathed organ technique with cat jejunum as the test organ, it was shown that kinin was regularly released by infusions of trypsin, chymotrypsin and nagarse into the blood superfusing the tissue or into the jugular vein of dogs.2. Intravenous injections of the three enzymes, in doses which did not change plasma bradykininogen (BKG) level, induced generation of kinin in the circulating blood.3. Nagarse in kinin-liberating concentrations did not liberate angiotensin in the circulating blood.4. The responses of the cat jejunum strip, and the systemic hypotension induced by the three enzymes, were enhanced by treatment of the dog with a bradykinin potentiator.5. Injection of the enzymes in the blood perfused hind leg of the dog caused a fall in the vascular resistance. In this preparation, bradykinin potentiating factor (BPF) potentiated trypsin, but not the effects of chymotrypsin and nagarse injections.6. It is suggested that the blood pressure lowering effect of low doses of trypsin is due mainly to kinin release. Chymotrypsin and nagarse, in addition to having a direct action on the vascular smooth muscles, also have indirect hypotensive effects due to the liberation of kinin.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5789813      PMCID: PMC1703611          DOI: 10.1111/j.1476-5381.1969.tb08016.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  POTENTIATION OF THE ACTION OF BRADYKININ ON SMOOTH MUSCLE BY CHYMOTRYPSIN, CHYMOTRYPSINOGEN AND TRYPSIN.

Authors:  H EDERY
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN.

Authors:  E G ERDÖS; J R WOHLER
Journal:  Biochem Pharmacol       Date:  1963-10       Impact factor: 5.858

3.  A micromethod for determination of bradykininogen under several conditions.

Authors:  C R DINIZ; I F CARVALHO
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

4.  Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma.

Authors:  S H FERREIRA; M ROCHA E SILVA
Journal:  Biochem Pharmacol       Date:  1962-12       Impact factor: 5.858

5.  A micromethod for the determination of bradykininogen in blood plasma.

Authors:  C R DINIZ; I F CARVALHO; J RYAN; M ROCHA E SILVA
Journal:  Nature       Date:  1961-12-23       Impact factor: 49.962

6.  CRYSTALLINE BACTERIAL PROTEINASE FROM B. SUBTILIS (NAGARSE) AS A NEW KININOGENASE.

Authors:  J L PRADO; E S PRADO; A JURKIEWICZ
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-01-01

7.  The detection and estimation of bradykinin in the circulating blood.

Authors:  S H Ferreira; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-03

8.  Release of kinins from fresh plasma under varying experimental conditions.

Authors:  M Rocha e Silva; M L Reis; S H Ferreira
Journal:  Biochem Pharmacol       Date:  1967-09-09       Impact factor: 5.858

9.  Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes.

Authors:  A P Corrado; M L Reis; I F Carvalho; C R Diniz
Journal:  Biochem Pharmacol       Date:  1966-07       Impact factor: 5.858

10.  Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom.

Authors:  S H Ferreira; M Rocha e Silva
Journal:  Experientia       Date:  1965-06-15
View more
  1 in total

1.  Effect of some clinically used proteolytic enzymes on inflammation in rats.

Authors:  A H M Viswanatha Swamy; P A Patil
Journal:  Indian J Pharm Sci       Date:  2008-01       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.